ELVN
Price
$22.97
Change
+$0.52 (+2.32%)
Updated
Jul 14, 04:59 PM (EDT)
Capitalization
1.32B
24 days until earnings call
VYGR
Price
$3.40
Change
-$0.09 (-2.58%)
Updated
Jul 14, 04:23 PM (EDT)
Capitalization
193.12M
17 days until earnings call
Interact to see
Advertisement

ELVN vs VYGR

Header iconELVN vs VYGR Comparison
Open Charts ELVN vs VYGRBanner chart's image
Enliven Therapeutics
Price$22.97
Change+$0.52 (+2.32%)
Volume$13.5K
Capitalization1.32B
Voyager Therapeutics
Price$3.40
Change-$0.09 (-2.58%)
Volume$200
Capitalization193.12M
ELVN vs VYGR Comparison Chart in %
Loading...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELVN vs. VYGR commentary
Jul 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELVN is a StrongBuy and VYGR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2025
Stock price -- (ELVN: $22.45 vs. VYGR: $3.49)
Brand notoriety: ELVN and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELVN: 62% vs. VYGR: 121%
Market capitalization -- ELVN: $1.32B vs. VYGR: $193.12M
ELVN [@Biotechnology] is valued at $1.32B. VYGR’s [@Biotechnology] market capitalization is $193.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $318.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELVN’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 2 green FA rating(s).

  • ELVN’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 2 green, 3 red.
According to our system of comparison, VYGR is a better buy in the long-term than ELVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELVN’s TA Score shows that 5 TA indicator(s) are bullish while VYGR’s TA Score has 5 bullish TA indicator(s).

  • ELVN’s TA Score: 5 bullish, 4 bearish.
  • VYGR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VYGR is a better buy in the short-term than ELVN.

Price Growth

ELVN (@Biotechnology) experienced а +8.30% price change this week, while VYGR (@Biotechnology) price change was +9.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +13.18%. For the same industry, the average monthly price growth was +23.65%, and the average quarterly price growth was +32.73%.

Reported Earning Dates

ELVN is expected to report earnings on Nov 06, 2025.

VYGR is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+13.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELVN($1.32B) has a higher market cap than VYGR($193M). ELVN YTD gains are higher at: -0.222 vs. VYGR (-38.448). VYGR has higher annual earnings (EBITDA): -97.25M vs. ELVN (-109.95M). ELVN has more cash in the bank: 290M vs. VYGR (236M). ELVN has less debt than VYGR: ELVN (365K) vs VYGR (42M). VYGR has higher revenues than ELVN: VYGR (67M) vs ELVN (0).
ELVNVYGRELVN / VYGR
Capitalization1.32B193M686%
EBITDA-109.95M-97.25M113%
Gain YTD-0.222-38.4481%
P/E RatioN/A6.00-
Revenue067M-
Total Cash290M236M123%
Total Debt365K42M1%
FUNDAMENTALS RATINGS
VYGR: Fundamental Ratings
VYGR
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
9
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ELVNVYGR
RSI
ODDS (%)
Bearish Trend 6 days ago
87%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
85%
Momentum
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
78%
MACD
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 6 days ago
78%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 25 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
84%
Aroon
ODDS (%)
Bullish Trend 4 days ago
80%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPEDX21.38-0.06
-0.28%
Alger Dynamic Opportunities A
BMECX14.98-0.06
-0.40%
BlackRock High Equity Income Investor C
MFRKX60.91-0.31
-0.51%
MFS Research R6
AFVLX22.79-0.19
-0.83%
Applied Finance Select Investor
ZSCCX30.82-0.51
-1.63%
Zacks Small-Cap Core Inv

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with DNLI. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
-1.45%
DNLI - ELVN
51%
Loosely correlated
-5.41%
ERAS - ELVN
50%
Loosely correlated
-4.61%
SYRE - ELVN
49%
Loosely correlated
-1.69%
CRNX - ELVN
48%
Loosely correlated
-0.19%
XNCR - ELVN
48%
Loosely correlated
-4.85%
More